Skip to Content
Merck

Proximity labeling in mammalian cells with TurboID and split-TurboID.

Nature protocols (2020-11-04)
Kelvin F Cho, Tess C Branon, Namrata D Udeshi, Samuel A Myers, Steven A Carr, Alice Y Ting
ABSTRACT

This protocol describes the use of TurboID and split-TurboID in proximity labeling applications for mapping protein-protein interactions and subcellular proteomes in live mammalian cells. TurboID is an engineered biotin ligase that uses ATP to convert biotin into biotin-AMP, a reactive intermediate that covalently labels proximal proteins. Optimized using directed evolution, TurboID has substantially higher activity than previously described biotin ligase-related proximity labeling methods, such as BioID, enabling higher temporal resolution and broader application in vivo. Split-TurboID consists of two inactive fragments of TurboID that can be reconstituted through protein-protein interactions or organelle-organelle interactions, which can facilitate greater targeting specificity than full-length enzymes alone. Proteins biotinylated by TurboID or split-TurboID are then enriched with streptavidin beads and identified by mass spectrometry. Here, we describe fusion construct design and characterization (variable timing), proteomic sample preparation (5-7 d), mass spectrometric data acquisition (2 d), and proteomic data analysis (1 week).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Hydroxylamine solution, 50 wt. % in H2O
Sigma-Aldrich
Iodoacetamide, Single use vial of 56 mg
Sigma-Aldrich
L-(−)-Glucose, ≥99%
Sigma-Aldrich
Human Plasma Fibronectin Purified Protein, from human plasma, liquid, 1 mg/mL (100 MG pack size is lyophilized), purified protein, suitable for cell culture